You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Irreversible Menin Inhibitor

Showing 1 - 25 of 8,304
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

Recruiting
  • Acute Myeloid Leukemia
  • +12 more
  • Los Angeles, California
  • +6 more
Jun 1, 2022

Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

Recruiting
  • Non Small Cell Lung Cancer
  • +16 more
  • Goodyear, Arizona
  • +10 more
Jan 24, 2023

Acute Myeloid Leukemia Trial in Houston (SNDX-5613, Venetoclax, ASTX727)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 14, 2022

Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)

Not yet recruiting
  • Liver Metastasis Colon Cancer
  • IRE plus checkpoint inhibitor
  • IRE plus Checkpoint Inhibitor plus CpG-ODN
  • (no location specified)
Sep 13, 2023

Type 2 Diabetes Trial in Canada, United States (BMF-219)

Recruiting
  • Type 2 Diabetes Mellitus
  • Montclair, California
  • +5 more
Feb 22, 2023

ALL, Adult, AML, Adult Trial (BN104)

Not yet recruiting
  • ALL, Adult
  • AML, Adult
  • (no location specified)
Sep 19, 2023

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, Poland (TG-1701, Umbralisib, Ublituximab)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • East Melbourne, Victoria, Australia
  • +7 more
Jan 20, 2023

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023

Part1: Advanced B-cell Malignancies, Part2: r/rCLL and r/rMCL, Part3: Untreated CLL Trial in Japan (Acalabrutinib, Obinutuzumab)

Active, not recruiting
  • Part1: Advanced B-cell Malignancies
  • +2 more
  • Chiba-shi, Japan
  • +13 more
Jan 31, 2022

HER2/Neu+ Uterine Serous Carcinoma Trial in Tucson, New Haven, Boston (Afatinib)

Recruiting
  • HER2/Neu+ Uterine Serous Carcinoma
  • Tucson, Arizona
  • +2 more
Feb 2, 2022

Glioblastoma, Brain Tumor, Recurrent Trial in Spain (PF-299804 (Dacomitinib))

Completed
Has Results
  • Glioblastoma
  • Brain Tumor, Recurrent
  • PF-299804 (Dacomitinib)
  • Badalona, Barcelona, Spain
  • +11 more
Jul 2, 2021

Metastatic Colorectal Cancer Trial in Køge (Irreversible electroporation, Calcium electroporation, Pembrolizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Irreversible electroporation
  • +2 more
  • Køge, Denmark
    Zealand University Hospital
Jan 27, 2023

Acute Leukemias, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (JNJ-75276617)

Recruiting
  • Acute Leukemias
  • +2 more
  • Duarte, California
  • +28 more
Jan 27, 2023

Advanced Malignant Solid Tumor, Bile Duct Carcinoma, Recurrent Malignant Solid Tumor Trial in Indianapolis, Seattle (Afatinib

Completed
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Afatinib Dimaleate
  • +2 more
  • Indianapolis, Indiana
  • +1 more
Jun 3, 2022

Lung Cancer, NSCLC (NSCLC) Trial in Tampa (Dasatinib - 1A, Afatinib - 1A, Dasatinib - 1B)

Completed
Has Results
  • Lung Cancer
  • Non-small Cell Lung Cancer (NSCLC)
  • Dasatinib - 1A
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 24, 2020

Pancreas Cancer Trial (Nivolumab, Irreversible electroporation (IRE))

Not yet recruiting
  • Pancreas Cancer
  • (no location specified)
Jun 27, 2022

Irreversible Pulpitis Trial in Cairo (nurofen)

Recruiting
  • Irreversible Pulpitis
  • Cairo, Egypt
    Cairo University
Jun 13, 2022

Myelofibrosis, Primary Myelofibrosis, Post-PV MF Trial in Canton (TL-895, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +13 more
Jan 10, 2023

Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)

Not yet recruiting
  • Diffuse Glioma
  • Malignant Glioma
  • Biospecimen Collection
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 6, 2023

Acute Myeloid Leukemia Trial in Worldwide (TL-895, KRT-232)

Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +33 more
Aug 3, 2022

Pancreas Cancer, Metastatic Trial in Aalborg (Pembrolizumab, Irreversible electroporation)

Active, not recruiting
  • Pancreas Cancer, Metastatic
  • Aalborg, North Denmark Region, Denmark
    Department of Oncology
Mar 8, 2022

Myelofibrosis Trial in Worldwide (TL-895)

Recruiting
  • Myelofibrosis
  • Aurora, Colorado
  • +65 more
Jun 2, 2022

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Amsterdam (Irreversible Electroporation (IRE), Nivolumab, Toll-Like

Recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Irreversible Electroporation (IRE)
  • +2 more
  • Amsterdam, North-Holland, Netherlands
    Amsterdam University Medical Centre (location VUmc)
Dec 18, 2022